C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2011
08/24/2011	EP2358678A1 Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
08/24/2011	EP2358677A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
08/24/2011	EP2358673A1 Novel bis-amides as antimalarial agents
08/24/2011	EP2358371A1 P2x3, receptor antagonists for treatment of pain
08/24/2011	EP2358365A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
08/24/2011	EP2358202A1 Benzimidazole and aza-benzimidazole carboxamides
08/24/2011	EP2358200A1 Substituted bicyclic amines for the treatment of diabetes
08/24/2011	EP1856095B1 Quinazoline derivatives as tyrosine kinase inhibitors
08/24/2011	EP1836164B1 11c-labeled benzyl-lactam compounds and their use as imaging agents
08/24/2011	EP1809610B1 Production method of pyrimidine compounds
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	CN1976923B Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
08/24/2011	CN102164912A Process for making quinolone compounds
08/24/2011	CN102164911A 1H-benzimidazole-5-carboxamides as anti-inflammatory agents
08/24/2011	CN102164910A Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-CARBOXAMIDINE derivatives having CB1-antagonistic activity
08/24/2011	CN102164909A Pyrine or pyrazine derivatives for treating HCV
08/24/2011	CN102164900A 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
08/24/2011	CN102164899A 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as FXR modulators against dyslipidemia and related diseases
08/24/2011	CN102164896A Phenethylamide derivatives and their heterocyclic analogues
08/24/2011	CN102164894A Heteroaryl antagonists of prostaglandin D2 receptors
08/24/2011	CN102164891A Substituted 1,2,3,4- tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
08/24/2011	CN102164485A Fungicidal pyridazines
08/24/2011	CN102161679A Compositions and methods for treating cancer
08/24/2011	CN102161656A Caspase inhibitors and uses thereof
08/24/2011	CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof
08/24/2011	CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof
08/24/2011	CN101812051B High purity fasudil hydrochloride compound
08/24/2011	CN101472580B Therapeutic or prophylactic agent for allergic dermatitis
08/23/2011	US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011	US8003799 Picolinic acid derivatives and their use as fungicides
08/23/2011	US8003798 Respiratory system disorders
08/23/2011	US8003796 Pyridone GPR119 G protein-coupled receptor agonists
08/23/2011	US8003795 Compounds and compositions for reducing lipid levels
08/23/2011	US8003792 Bicyclic anilide spirolactam CGRP receptor antagonists
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011	US8003789 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile
08/23/2011	US8003670 Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands
08/23/2011	US8003669 Remedy for sleep disturbance
08/23/2011	US8003668 Use of 2-(amino-substituted piperidin-1-yl)benzimidazoles as antidiabetic agents, or to treat carbohydrate and lipid metabolic disorders; use in combination with other drugs; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-yl]-benzenesulfonamide or salts for example
08/23/2011	US8003664 Indazole-carboxamide compounds
08/23/2011	US8003660 Modulators of muscarinic receptors
08/23/2011	US8003659 Macrocyclic serine protease inhibitors
08/23/2011	US8003657 Heterocyclic substituted bisarylurea derivatives
08/23/2011	US8003653 Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's disease
08/23/2011	US8003650 Hydrazide compound and harmful arthropod-controlling agent containing the same
08/23/2011	US8003643 Inhibitors of Akt activity
08/23/2011	US8003642 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
08/23/2011	US8003638 7-pyrazolylbenzazepines having affinity for D3 receptor
08/23/2011	US8003229 Ambipolar host in organic light emitting diode
08/23/2011	CA2656535C Alkyne-substituted pyridone compounds and methods of use
08/23/2011	CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors
08/23/2011	CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors
08/23/2011	CA2458632C Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
08/18/2011	WO2011100380A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
08/18/2011	WO2011100282A2 Imatinib mesylate polymorphs
08/18/2011	WO2011099039A1 Process for the preparation of alpha form of imatinib mesylate
08/18/2011	WO2011098938A1 Novel solvate of dexlansoprazole
08/18/2011	WO2011098776A1 5-ht receptor modulators
08/18/2011	WO2011098553A1 Preparation process of the sodium salt of esomeprazole
08/18/2011	WO2011098408A2 Hydrazine-substituted anthranilic acid derivatives
08/18/2011	WO2011082267A8 Substituted triazolo-pyrazine compounds
08/18/2011	WO2011080751A3 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
08/18/2011	WO2011018415A3 Microbiocidal heterocycles
08/18/2011	US20110201815 Fused heterocyclic derivative and use thereof for medical purposes
08/18/2011	US20110201811 Dihydropyridine calcium antagonist compounds, preparation methods, and medical uses thereof
08/18/2011	US20110201804 Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
08/18/2011	US20110201652 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists
08/18/2011	US20110201650 Cyclohexane derivative and pharmaceutical use thereof
08/18/2011	US20110201649 agricultural composition
08/18/2011	US20110201648 Poly-heteroaryl derivatives for the treatment of cancer
08/18/2011	US20110201647 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
08/18/2011	US20110201644 Crystalline form of a benzimidazole-carboxamide medicinal compound
08/18/2011	US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
08/18/2011	US20110201632 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists
08/18/2011	US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists
08/18/2011	US20110201621 Angiotensin ii receptor antagonists
08/18/2011	US20110201619 Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders
08/18/2011	US20110201616 Sulfonamide compounds or salts thereof
08/18/2011	US20110201615 Triazole beta carboline derivatives as anti-diabetic agents
08/18/2011	US20110201613 Fungicide hydroximoyl-tetrazole derivatives
08/18/2011	US20110201609 Proteasome inhibitors for selectively inducing apoptosis in cancer cells
08/18/2011	US20110201607 Fused heterocyclic m1 receptor positive allosteric modulators
08/18/2011	US20110201606 Pyrimidine derivatives
08/18/2011	US20110201605 Heteroaryl substituted piperidines
08/18/2011	US20110201603 Novel Acylaminobenzamide Derivatives
08/18/2011	US20110201602 Protein kinase modulators and method of use
08/18/2011	US20110201599 CDK Modulators
08/18/2011	US20110201592 Therapeutic Oxy-Phenyl-Aryl Compounds and Their Use
08/18/2011	US20110201591 Isonicotinamide orexin receptor antagonists
08/18/2011	US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/18/2011	US20110201583 Guanidine-containing compounds useful as muscarinic receptor antagonists
08/18/2011	US20110201581 Novel Compounds 010
08/18/2011	US20110201580 Pyrrolidine derivatives
08/18/2011	US20110201496 Substituted 5-Hetaryl-4-Aminopyrimidines
08/18/2011	US20110200581 Pharmaceutical compositions
08/18/2011	US20110200536 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
08/18/2011	US20110198574 Quinoxaline Derivative, and Light-Emitting Device, Electronic Device Using the Quinoxaline Derivative
08/18/2011	US20110198571 Organic compound and organic electroluminescence device employing the same
08/18/2011	CA2789989A1 Process for the preparation of alpha form of imatinib mesylate
08/18/2011	CA2789806A1 5-ht receptor modulators

1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 1080